Functional evidence implicating S100P in prostate cancer progression.
about
The life and works of S100P - from conception to cancerQuantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progressionFollow-up study of abnormal biological indicators and gene expression in the peripheral blood of three accidentally exposed personsNBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.Comparison of lung cancer cell lines representing four histopathological subtypes with gene expression profiling using quantitative real-time PCR.S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer.S100P: a novel therapeutic target for cancer.Di-ethylhexylphthalate (DEHP) modulates cell invasion, migration and anchorage independent growth through targeting S100P in LN-229 glioblastoma cellsThe expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancerLatexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.Evidence for the importance of personalized molecular profiling in pancreatic cancer.S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors.S100 proteins in cancer.A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours.Differential DNA methylation profile of key genes in malignant prostate epithelial cells transformed by inorganic arsenic or cadmiumHigh expression of S100P is associated with unfavorable prognosis and tumor progression in patients with epithelial ovarian cancerIdentification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.S100P expression in response to sex steroids during the implantation window in human endometrium.S100 protein family in human cancer.Transcriptional regulation and functional implication of S100P in cancer.Calcium-binding protein S100P and cancer: mechanisms and clinical relevance.Joining S100 proteins and migration: for better or for worse, in sickness and in health.Glucocorticoid receptor-mediated transcriptional activation of S100P gene coding for cancer-related calcium-binding protein.S100P is associated with proliferation and migration in nasopharyngeal carcinoma.S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion.S100P regulates trophoblast-like cell proliferation via P38 MAPK pathway.Expression array analysis of the hepatocyte growth factor invasive program.Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.MicroRNA-183 regulates Ezrin expression in lung cancer cells.Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistanceSignificance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.Fatty Acids and Calcium Regulation in Prostate Cancer.
P2860
Q26749135-33CB86F6-5AB2-4EF0-83B8-450F1B78D803Q28286300-8B01359D-EE53-44A3-9E36-9FC402782A23Q30544265-912C8649-7571-49B0-AE98-0D476ED8EB03Q30651336-A34D823A-DCE7-460E-BDE0-40AA6DE819BAQ33634644-B01630B2-AED5-4D2E-80B3-C31B4EA7FB4AQ33685170-CF729D31-2C80-4D73-9178-CB3E12F97046Q33699305-EAB255FF-A993-49B2-BA2A-B7A2CCEB0624Q33742292-9AF97102-5041-4737-ADD4-21424134DD6EQ33802820-A61B9E95-B377-4C09-A526-43754E68339EQ33863314-8298A7DE-852E-44D3-A1D3-7F932B9C2236Q34387784-707ECC2C-61D6-4654-882D-1AACD53F680BQ34778723-244D4968-F7FB-458D-BEEB-249E79A30A3BQ35206368-90E5AAD5-C925-4486-BCF4-0735D98EF4F7Q35337546-9862273A-7139-4326-A717-2C63ECF67037Q35706402-7E298F5D-C670-4A81-A7AE-C6DD1D6F29BBQ36057106-F90D5583-CCC7-465C-A876-582EA990E7BAQ36299781-8F67C8E1-29C8-4803-BFBE-1C748AFB622FQ36552663-FF2D4709-D189-405C-BC90-E86BD90C8911Q37650123-D1E2D95E-89AE-4A11-A3D6-06FA708DB1BDQ37692260-EC73C06D-0E79-4908-9944-D005D3DC4417Q37938716-122FCAF3-B911-4EE5-9CBB-5174842DB9A7Q38118075-1E699EAD-1552-433B-9F53-DB1D954E8D8AQ38333462-E4061415-20E4-46D5-8D56-8CCB86276C43Q38686041-962D6ABD-F635-4408-B90A-2E17193FB3CCQ38727593-C28BCD35-ED36-46C5-A4F7-E1BEDC08109CQ38842282-F699D4DA-8B38-4BAD-A09D-FC12BC80ED4FQ38847534-9B744B17-53E6-4189-B58A-4989D8D0EF4EQ39492998-38B3A2F2-448E-4EDA-A913-6CC765FADDB6Q39931717-F2D5A6D2-ABF6-4F5B-8414-4127D9B7DEEEQ40859595-8D82CC74-1624-4D53-8BDA-89D9642C2430Q41030727-A5F30E26-07CC-4BBE-BEEA-F4B74A806687Q55468609-7C14EB7D-E8B7-4F4D-A86C-C970A9A0FE6B
P2860
Functional evidence implicating S100P in prostate cancer progression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Functional evidence implicating S100P in prostate cancer progression.
@en
type
label
Functional evidence implicating S100P in prostate cancer progression.
@en
prefLabel
Functional evidence implicating S100P in prostate cancer progression.
@en
P2093
P356
P1476
Functional evidence implicating S100P in prostate cancer progression.
@en
P2093
Angela M Rojas
David O Azorsa
Gargi D Basu
Jeffrey A Kiefer
Jeffrey M Trent
Michael T Barrett
Spyro Mousses
P304
P356
10.1002/IJC.23447
P577
2008-07-01T00:00:00Z